The mechanism of carperitide-induced renal protective effects during cardio-thoracic vascular surgery.

The mechanism of carperitide-induced renal protective effects during cardio-thoracic vascular surgery. - Carperitide-induced renal protective effects

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012312

Enrollment

Registered

2013-11-18

Start date

2013-11-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardiac infarcton aorta aneurysm

Interventions

continuous intravenous infusion of carperitide 0.025ganma from start to end of surgery control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients receiving cardio-thoracic surgery

Exclusion criteria

Exclusion criteria: dialysis patient

Design outcomes

Primary

Measure	Time frame
plasma angiotensinII concentration urinary angiotensinogen concentration urinary NGAL concentration	—

Countries

Japan

Contacts

Public ContactMoriyama Takahiro

Kagoshima university Department of anesthesiology

takmor@m3.kufm.kagoshima-u.ac.jp099-275-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026